However, the lack of extensive studies and FDA approval for weight loss specifically may deter some patients
Patients showed an average reduction of 13.7% of body weight with semaglutide
Blocking NNMT activity has been shown in research settings to influence body composition, leading to reduced adipocyte size, alterations in fat mass, and measurable changes in plasma biomarkers such as glucose and cholesterol
Vitamin B12 (also called cobalamin) is a water-soluble vitamin your body relies on to make energy, protect your nerves, and produce healthy blood cells
Dosage: 1,000 mcg is the typical dose for most adults
General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
%20(1).png)
